{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7716,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a timeline visual to connect high-level goals with specific 2024 milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/6",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a split layout with a left-hand sidebar for board/advisors and a right-hand grid for the leadership team.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/7",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a standard pharmaceutical pipeline visualization format.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/8",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) and their respective treatment challenges.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/9",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "6ae75f7a-47cc-48a2-b40a-7dbce9a7533d",
          "evidence": "The deck presents the limitations of current treatment options",
          "position": 0,
          "objective": "What are the consequences of not addressing the limitations of current treatment options?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 9,
          "beatId": "85fc4c77-7ee9-4cb1-a74a-3c9707aa8512",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The deck presents the problem of emerging resistance mutations, increasing CNS involvement, and treatment-related adverse events",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a case study (Osimertinib) to validate the proposed strategy for ALK/ROS1 targets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/10",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 10,
          "beatId": "a8e420e9-9c9e-4d1c-a1ef-2d1d5f7361f9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential best-in-class solution",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The chart uses a bar-horizontal format to compare sales figures for specific drugs (Alectinib, Crizotinib) against a group of 'Other' TKIs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/11",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 11,
          "beatId": "264d16ee-9620-4300-9489-2af8bc5857b9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Size",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "The deck presents the market sizing for Nuvalent's potential products",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a sidebar 'AT A GLANCE' to summarize key clinical development parameters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/12",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "customer_journey",
      "function": "present_framework",
      "notes": "The slide uses a timeline-based framework to map treatment lines (1L, 2L, 3L+) against clinical challenges.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/13",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a matrix-style comparison to highlight the superior coverage of NVL-655 compared to 1st, 2nd, and 3rd generation inhibitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/14",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a split-screen layout to contrast in vitro IC50 data with in vivo tumor regression data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/15",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses two distinct chart types (bar and scatter) to demonstrate pharmacological advantages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/16",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes detailed patient enrollment breakdown by dose cohort and trial phase.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/17",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Clinical trial baseline characteristics table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/18",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. Includes detailed breakdown of response by mutation type and prior treatment history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/19",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Clinical trial data (ALKOVE-1) showing efficacy of NVL-655 in NSCLC patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/20",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart is a classic swimmer plot used in oncology clinical trials to visualize time-to-event data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/21",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "product_demo",
      "function": "illustrate_case",
      "notes": "Includes two patient case studies with MRI scans showing tumor reduction.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/22",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. N=93 patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/23",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart shows NVL-655 pharmacokinetics across five dose cohorts, highlighting that the 150mg dose maintains levels above efficacy thresholds for various ALK mutations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/24",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and define the specific clinical opportunity for each.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/25",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes a table detailing patient cohorts and study objectives.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/26",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a sidebar 'AT A GLANCE' to summarize key clinical and regulatory status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/27",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "customer_journey",
      "function": "frame_problem",
      "notes": "Uses a timeline-based framework to contrast current treatment standards with unmet clinical needs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/28",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a visual comparison matrix to highlight the therapeutic advantages of Zidesamtinib.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/29",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses three distinct chart types to demonstrate competitive superiority in potency, CNS penetration, and selectivity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/30",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide provides a detailed breakdown of patient enrollment across different dose cohorts (25mg to 125mg QD) for the ARROS-1 trial.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/31",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Clinical trial baseline characteristics table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/32",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a waterfall plot and a summary table of best responses.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/33",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes clinical trial data for Zidesamtinib (NVL-520) in ARROS-1 Phase 1 study.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/34",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
      "docSlug": "d223628377f56d072b5dbf426c21baf1",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data from ARROS-1 Phase 1 trial.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/35",
      "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
      "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}